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Abstract
Purpose: There is a bidirectional link between uncontrolled diabetes and untreated
periodontal disease. Controlling periodontal infection plays an essential role in the overall
management of diabetes. This study explored an interprofessional (IP) collaboration
between Certified Diabetes Care and Education Specialists (CDCES) and Dental
Hygienists and the utility of a point of care Periodontal Screening Tool (PST) for CDCES
to build confidence in informing their clients on periodontal disease risk factors and
providing resources to seek dental care.
Methods: This pilot study used a pre-test post-test design where a survey was
administered prior to CDCES participating in an Education and Training Module on the
oral systemic link, periodontal risk factors, and instruction for the PST. A post-survey
two weeks after module participation and use of the PST was administered with similar
pretest items as well as qualitative items.

Results: Pre- and post-test scores for participants (n=4) in this pilot study suggests the
use of the PST with an IP Education and Training Module resulted in the CDCES’ increased
confidence in informing the patient about periodontal disease risk factors and providing
resources to seek dental care. All of the CDCES (100%) reported using the Periodontal
Screening Tool increased their confidence in recommending patient for dental care.

Although, the sample size could not attain significance, findings support this pilot study
is feasible.
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Conclusion: An IP collaboration and Periodontal Screening Tool for CDCES could
translate to individuals with poorly controlled diabetes seeing the dentist or dental
hygienist for evaluation and treatment.
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Introduction/Literature Review
Introduction to the Research Question
Diabetes affects an estimated 422 million adults worldwide (World Health
Organization [WHO] Global Report on Diabetes, 2016). Periodontal disease is the sixth
most common complication of diabetes (Loe, 1993). As reported in the current American
Academy of Periodontology [AAP] Fact Sheet (2019), half of Americans 30 years of age
and older have periodontitis, a severe form of periodontal disease affecting an estimated
64.7 million Americans. The overarching message from the Office of the Surgeon
General states oral health is essential to the general health and well-being of all
Americans (Surgeon General Priority: Oral Health, 2019).
A landmark study by Shlossman, Knowler, Pettit, & Genco (1990) explored the
relationship between oral health and systemic diseases. The relationship between oral
health and systemic diseases, such as cardiovascular disease and diabetes, continues to be
explored and is referred to as the oral-systemic link (Genco & Williams, 2010; Joseph,
Kullman, & Sharma, 2016). Researchers speculate inflammation may be the basis for this
connection and call for additional research to better understand how treating periodontal
disease may reduce the risk of developing and/or worsening complications from
inflammatory diseases.
Registered Dental Hygienists (RDH) are specifically educated in assessing,
diagnosing, treating, and evaluating periodontal disease. Certified Diabetes Care and
Education Specialists (CDCES) provide education, support, and care management for the
diabetic patient. They advocate for individuals with diabetes by promoting self-
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management to achieve behavioral and treatment goals to minimize risk and optimize
health outcomes. Both RDH and CDCES are essential in treating and managing patients
with diabetes. With the increased risk factors associated with diabetes it, is important to
include an educational screening tool for periodontal risk factors as part of interprofessional collaborative care.
Statement of Problem
Diabetes and periodontal disease are common but complex conditions. The
number of Americans with diabetes is projected to double or triple by 2050 (American
Association of Diabetes Educators [AADE], 2017). Periodontal disease is prevalent in
both developed and developing countries and affects an estimated 20-50% of global
populations (American Academy of Periodontology [AAP] Fact Sheet, 2019).
Periodontal disease is prevalent in adolescents, adults, and geriatric individuals, making it
a public health concern (Nazir, 2017). There is an increased risk in prevalence and
severity of periodontal disease in individuals with poorly controlled diabetes (Tandon et
al., 2015; Molina et al., 2016; Zuikaite, Slot, & Van der Weijden, 2018). The
bidirectional relationship between diabetes and periodontal disease and the mechanism by
which this occurs remains the topic of ongoing research (Chapple & Genco, 2013;
Casanova, Hughes, & Preshaw, 2014; Agarwal, Chaubey, Mada, & Agarwal, 2016;
Fatima et al., 2017). The inference can be made that individuals with diabetes are likely
to have periodontal disease and vice versa. The treatment of periodontal disease may
contribute to improvements in health, not only in the oral cavity but throughout the body
(Sabharwal et al., 2018).
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Conventional non-surgical periodontal therapy may help reduce and control
glycemic levels (HbA1c). The term HbA1c refers to a blood test that indicates the
presence of excessive sugar in the bloodstream over a three-month period. Similarly,
improved glycemic control may help improve periodontal disease. Considering the
potential impact of periodontitis on HbA1c, thus increasing the risks of other diabetic
complications, it is important to include the treatment of periodontal disease as an
integral element of diabetes care. Based on this, coordination between CDCESs, who are
experts in diabetes management, and dentists and dental hygienists, who are experts in
periodontal disease, is necessary. Providing a tool for periodontal disease risk assessment
for CDCES could translate to individuals with poorly controlled HbA1c seeing the dentist
or dental hygienist for evaluation and treatment. Results from this study could contribute
to interprofessional education and collaboration among all care providers of the diabetic
patient (ADHA Research Agenda, 2016).
Research Questions
There is a gap in the research regarding the utility of a Periodontal Screening Tool
for non-dental health care providers. To address this deficiency, this proposed study seeks
to answer the following questions:
•

Does a Periodontal Screening Tool, accompanied by training on how to
use this tool, increase CDCES’s confidence in informing the patients on
periodontal disease risk factors?

•

Does the CDCES’s confidence result in their providing resources for their
patients to seek dental care?

PERIODONTAL RISK FACTOR EVALUATION TOOL

4

Overview of Research
This study explored how diabetes and periodontal disease are related and how the
treatment of one affects the other. It investigated interprofessional collaboration between
the medical and dental communities, specifically CDCES and RDH, as well as offered a
possible solution in connecting healthcare providers in support of each other in providing
total patient care.
Diabetes
The American Diabetes Association [ADA] (2016) describes diabetes as a
pathological consequence of physiological changes resulting in metabolic dysregulation,
hyperglycemia, and chronic inflammation. Diabetes mellitus, commonly known as
diabetes, is a chronic systemic disease that occurs when the pancreas does not produce
enough insulin (a hormone that regulates blood sugar) or when the body cannot
effectively use the insulin produced or the insulin produced is defective. Insulin is a
hormone that moves glucose (sugar) from the blood into the cells to be stored or used for
energy. It regulates blood glucose by allowing cells to absorb and use glucose, which
lowers blood glucose levels (A1C). If the amount of insulin available is insufficient, cells
respond poorly to the effects of insulin. This is known as insulin resistance. If the insulin
itself is defective, glucose is not absorbed properly or stored appropriately by the body
cells that require it. When this occurs, the net effect is persistently higher than normal
levels of blood glucose, poor protein synthesis, and other metabolic derangement.
Deficiency of insulin or the insensitivity of its receptors is at the center of all forms of
diabetes (Little et al., 2018) (see Figure 1).
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Figure 1
Deficiency of Insulin and Diabetes

Note. The net effect of defective insulin, insufficient insulin, and/or insulin resistance
Specific types of diabetes include Type 1, Type 2, Genetic Defects of the B-cell,
Diseases of the Exocrine Pancreas, Endocrinopathies, Drug or Chemical-Induced
Diabetes, Infections, and Gestational. There are also several uncommon forms of
immune-mediated and genetic syndromes sometimes associated with diabetes. Currently,
in the United States 30.3 million people have been diagnosed with diabetes and 84.1
million people are considered prediabetic. Diabetes typically presents as Type 1 or Type
2, the latter accounts for 90-95% of diagnosed cases (American Association of Diabetes
Educators [AADE], 2017).
Type 1 diabetes (DM1) is an autoimmune response in which the pancreas no
longer produces insulin to control blood sugar. The immune system mistakenly attacks
and destroys insulin-producing beta cells in the pancreas. To avoid hyperglycemia (too
much) or hypoglycemia (too little blood sugar), individuals with DM1 must be managed
with insulin injections to help their bodies use glucose efficiently. For this reason, DM1
is also referred to as insulin-dependent diabetes mellitus or juvenile diabetes (Little et al.,
2018).

6
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Type 2 diabetes (DM2) begins with insulin resistance, a condition where cells
cannot effectively use the insulin the pancreas produces. The most common cause for
developing DM2 is a combination of obesity and insufficient exercise. In the beginning
stages, extra insulin is produced, causing the blood glucose to rise higher than normal
(hyperglycemia). Over time insulin production is less than ideal, resulting in unhealthy
fluctuations in blood sugar (glucose) levels. This condition is managed with medication
with or without insulin (Little, et al., 2018).
Several methods are used to diagnose diabetes. Diagnosis of diabetes is
determined daily by measuring fasting levels of serum glucose (A1c) and levels of
glycosylated hemoglobin over a 2-3-month period (HbA1c). The ADA, (2016),
recommends the following criteria for the diagnosis of diabetes: HbA1c > 6.5%, fasting
plasma glucose > 126mg/dl, random plasma glucose > 200mg/dl, and two-hour plasma
glucose > 200mg/dl. (see Table 1).
Table 1
Diabetes Guidelines
Assay

Description

Criteria
for
Diabetes

HbA1c

Performed in laboratory by method NGSPcertified and standardized to DCCT assay

> 6.5%

Fasting plasma
Glucose (A1c)

At least eight-hour fast

> 126mg/dl

Random plasma
Glucose

In persons with symptom of hyperglycemia or
hyperglycemic crisis: Blood glucose measured
at any time of day

> 200 mg/dl

Two-hour
Plasma glucose

Following a glucose load of 75 g anhydrous
glucose dissolved in water

> 200mg/dl

Adapted from ADA, (2016).
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The ADA lists the following long-term complications associated with DM2:
retinopathy (eyes), neuropathy (nerve damage), nephropathy (kidney), cardiovascular
disease (heart), peripheral vascular disease (arteries), and periodontal disease (oral
cavity). Individuals with DM2 are also prone to infection and experience slow wound
healing (ADA Diabetes Management Guidelines, 2016). In addition to periodontal
disease, oral complications associated with diabetes may include salivary dysfunction
(xerostomia or dry mouth), bacterial, viral, and fungal infections (including candidiasis),
neurosensory disorders (burning mouth syndrome), increased incidence and severity of
dental caries, and periapical abscesses (Little et al, 2018).
Two of the biggest challenges for individuals with DM2 are stable glucose levels
at the time the blood is sampled and maintaining stable HbA1c glucose levels. The
normal range for HbA1c is between 4% and 5.6%. Individuals with DM2 have HbA1c
levels of 6.5% or higher. The higher the glucose concentration in the blood, the higher the
detectable hemoglobin (ADA, 2016) (see Figure 2). Unstable or uncontrolled glucose
levels increases the risks associated with diabetes. The successful management of these
complications has been shown to have a positive impact on the quality of life (QoL.) for
the diabetic individual (Mizumo et al., 2017).
Complications from diabetes have a fiscal impact as well. Economic loss due to
the complications of diabetes affects individuals and their families, health systems, and
national economies through direct medical costs and loss of work and wages (World
Health Organization [WHO] Global Report on Diabetes, 2016). The global economic
burden is estimated to increase in the United States from $1.3 trillion in 2015 to $ 2.1
trillion by 2030 (Bommer et al., 2018).

8
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Figure 2
Levels of Control and Numerical Ranges for HbA1c or A1c
HbA1c %
Well Controlled
Moderately Controlled

Uncontrolled

A1c Fasting mg/dl
4%
5%

114mg/dl

Less than 160mg/dl

6%
6.5%
7%

126mg/dl
140mg/dl
154mg/dl

Less than 160mg/dl

7.5%
8%
8.5%
9%
9.5%
10%

169mg/dl
183mg/dl
197mg/dl
210mg/dl
226mg/dl
240mg/dl

Greater than 160mg/dl

Diabetes Treatment and Management. Hyperglycemia is at the center of
diabetes treatment. Treatment protocol is determined by a medical doctor and is dictated
by the needs of the individual patient. DM2 treatments include diet, exercise, medication,
and insulin therapy. Because obesity is a contributing factor in developing and managing
diabetes, physical activity level (exercise), nutrition (healthy eating and portion control),
and community support for weight loss is prescribed and is often under the supervision of
a registered dietitian and exercise specialist. When life-style changes (diet and exercise)
are ineffective in controlling blood glucose levels, medications with or without insulin
are prescribed as an adjunct (ADA, 2020). Oral medications are the first kind of medicine
prescribed in the treatment of DM2 when diet and exercise are not enough (see Figure 3).
Insulin therapy is prescribed when oral medications alone are ineffective controlling
HbA1c. Types of insulin are grouped according to how fast they work and how long the
effects last (see Table 2).

9

PERIODONTAL RISK FACTOR EVALUATION TOOL
Figure 3
Type 2 Diabetes Oral Medications
TYPE
Alpha-glucoside
inhibitors

MEDICATION
Acarbose (Precose)
Miglitol (Glyset)

Dopamine receptor
agonist

Bromocriptine mesylate
(Cycloset, Parlodel)

•

Biguanides

Metformin (Fortamet,
Glucophage, Glucophage XR,
Glumetza, Riomet)

•

DPP-4 inhibitors

Aloglipitin (Nesina)
Linagliptin (Tradjenta)
Saxagliptin (Onglyza)
Sitagliptin (Junuvia)

•

•
•

•

•
•

SGLT2 inhibitor

Sulfonylureas

Meglitinides

Bile acid
sequestrants

Canagliflozin (Invokana)
Dapagliflozin (Farxiga)
Empagliflozin (Jardiance)

•

Chlorpropamide (Diabinese)
Glimepiride (Amaryl)
Tolazamide (Tolinase)
Tolbutamide (Orinase)
Glyburide (DiaBeta,
Micronase, Glynase Pre Tab)
Glipizide (Glucotrol, Gluterol
XL)
Nateglinide (Starlix)
Repaglinide (Prandin)

•

Colesevelam (Welchol)

•
•

•

•

•

ACTION
Blocks enzymes that
help digest food
Slows the rise of blood
glucose
Raises level of
dopamine
Helps improve blood
glucose control
Improves the ability of
insulin to move glucose
into cells, especially
muscle
Signals the pancreas to
release insulin
Boosts insulin levels
when blood glucose is
too high
Signals liver to cut back
on glucose production
Increases amount of
glucose in urine
Blocks kidneys form
reabsorbing glucose
Prompts pancreas to
release insulin
Helps body use insulin
efficiently

Boosts insulin release
from pancreas when
blood glucose is too
high
Lowers cholesterol
Lowers blood glucose

10
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Table 2
Injectable Insulin Therapy
TYPE
Rapid Acting

ONSET
15 minutes

PEAK
At 1 hour

DURATION
2-4 hours

Regular or
Short-Acting

Within 30 minutes

2-3 hours

3-6 hours

Intermediate-Acting
Long Acting

2-4 hours
2 hours

4-12 hours
12-18 hours
Lowers glucose levels nearly
evenly over 24-hour period

Individuals with diabetes must learn to manage their disease through diabetes
self-management training that includes glucose monitoring, adjustments in diet and
exercise, taking medication as directed, returning periodically to see the physician as
recommended, and seeing the dentist or hygienist for a periodontal evaluation.
Periodontal Disease
Periodontal disease is prevalent in adolescents, adults, and geriatric individuals
making it a public health concern (Nazir, 2017). It is estimated by the American
Association of Periodontology (AAP) 64.7 million Americans have periodontal disease,
defined as an inflammatory disease affecting the soft tissues (gingiva) and bone that
support the teeth (AAP Fact Sheet, 2018). Moderate periodontitis in adults is estimated to
affect 40-60% worldwide (Chapple & Genco, 2013).
Several factors influence the severity of periodontitis and contribute to
progression including poor oral hygiene, age, diet, genetic susceptibility, and
medications. Local factors such as poorly placed and/or ill-fitting crowns or fillings
promote gingival inflammation and clinical attachment loss. Smoking and stress are
environmental factors that decrease host immune function, resulting in increased
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susceptibility to disease. Systemic diseases, such as diabetes and cardiovascular disease,
can alter host defense mechanisms and deregulate the inflammatory response, resulting in
a decrease in host defense to bacterial infection (Genco & Williams, 2010).
Gingivitis and Periodontitis. Periodontal disease has two stages: gingivitis and
periodontitis. Gingivitis occurs when the body recognizes the bacterial biofilm (dental
plaque) as harmful or foreign. Dental plaque is a biofilm of soft, sticky, colorless
bacterial colonies that adhere to the tooth surface above the gumline (supragingival) and
below (subgingival). The bacteria located within the infected gingiva are pathogenic,
highly inflammatory, and able to survive in the blood stream and thus contribute to
infection in other areas of the body (Poudel et al, 2018). Dental plaque is unique to the
individual and although it cannot be eliminated, it can be reduced and controlled with
regular and thorough brushing and flossing. In some individuals, dental plaque can
mineralize due to an exchange of calcium and phosphate ions present in saliva, forming a
hard deposit called calculus. Calculus can be subgingival or supragingival (Walsh,2020).
Once calculus forms, the toothbrush, dental floss, and/or oral hygiene aids are ineffective
at removing it. The successful removal of calculus can only be accomplished by a dentist
or dental hygienist, typically in a clinical setting.
In reaction to dental plaque, the inflammatory response is activated. The blood
vessels dilate, becoming too fragile to accommodate an increase in clean-up cells, called
macrophages and phagocytes, to fight the infection. The gingiva is red, swollen, and
bleeds easily. At this point, the process is reversible with the mechanical removal of the
dental biofilm and calculus. If not reversed or interrupted, gingivitis may progress to
periodontitis, which is irreversible. In this reaction, inflammatory mediators, including
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interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-a), prostaglandins, and cytokines
are stimulated, which results in damage to the underlying bone support (Grossi & Genco,
1998; Mesia et al., 2016; Dogan et al, 2016). This in turn results in a periodontal pocket
measurable with a periodontal probe (see Figure 4). If not arrested, further destruction
occurs, resulting in bone loss that can be seen on a dental radiograph or x-ray (see Figure
5). Extensive bone-loss causes the teeth to loosen and eventually fall out (AAP, 2018).
Figure 4
The Progression of Periodontal Disease

Darling-Fisher et al., (2015). DOI: https://doi.org/10.1016/j.nurpra.2015.08.001
Note. Periodontal disease progresses from healthy to unhealthy and reversible to
irreversible.
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Figure 5
Periodontal Disease and Destruction/Bone Loss

Used with permission https://doi.org/10.1038/ki.2008.660

Note. Figure 5 is two-part: Diagram (a) is a graphic depicting a tooth with healthy
cementum, connective tissue, and alveolar (jaw) bone on the left side and compromised
due to periodontal disease on the right side. Diagram (b) illustrates a radiographic image
of optimal bone support on the left side and bone loss on the right.
The dentist, periodontist, or dental hygienist performs a periodontal examination
to determine the presence and extent of periodontal disease, consider the cause, and plan
treatment accordingly (AAP, 2018).
Based on a model of staging and grading, with the addition of smoking and
diabetes as modifiable risk factors, a universal classification system for periodontitis was
developed as part of the 2017 World Workshop on periodontal disease (Papanous et al.,
2018). The concept of staging has been extensively developed in the field of oncology.
Staging of tumors is based on current observable clinical presentation, including severity
and extent of disease and considers complexities of case management. To supplement
staging, grade is used to assess the potential for tumor progression. In addition, molecular
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markers often guide drug therapies, and thereby incorporate biological targets, thus
increasing the probability for favorable outcomes (Tonelli, et al., 2018).
Figures 6 and 7 depict the Universal Classification System for Periodontitis based
on stage and grade. Staging is largely dependent upon the severity of disease according to
the level of interdental clinical attachment loss (CAL), radiographic bone loss and tooth
loss, extent, and distribution as well as the anticipated complexity of disease management
(Papanous et al., 2018). The goals of staging periodontitis are 1) to classify severity and
extent of disease based on currently measurable content of destroyed and damaged tissue
and 2) to assess specific factors that may determine complexity of controlling current
disease and managing long-term function and esthetics of dentition (Tonelli et al., 2018).
Grading is used as an indicator of the rate of periodontitis progression: slow,
moderate, or rapid. Grade is established based on direct evidence (radiographic bone loss
or CAL) or indirect evidence (% of bone loss/age and/or case phenotype) of progression.
Once grade is established based on evidence of progression, it can be modified based on
the presence of two modifiable risk factors: smoking (<10 cigarettes/day or >10
cigarettes/day and diabetes (HbA1c <7.0% or HbA1c >7.0%). Grading provides
supplemental information, including anticipated treatment responses or outcomes and
effects on systemic health (Papanous, 2018). The purpose for grading periodontology is
two-fold: 1) To estimate future risk for disease progression and responsiveness to
treatment and to guide intensity of therapy and monitoring and 2) to estimate the potential
health impact of periodontitis on systemic disease and to guide systemic monitoring and
co-therapy with medical colleagues (Tonelli, et al., 2018).
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Figure 6
Staging of Periodontitis

Tonelli, Greenwall, & Kornman DOI: 10.1002/JPER.18-0006
Figure 7
Grading of Periodontitis

Tonelli, Greenwall, & Kornman DOI: 10.1002/JPER.18-0006
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Role of the Dental Hygienist in Periodontal Therapy. Periodontal therapy is the
mechanical removal or debridement of calculus performed by a dental hygienist. A dental
hygienist is a licensed dental professional who specializes in the health of the mouth (oral
cavity). They are educated in accordance with the Commission on Dental Accreditation
(CODA) standards and tested at the national and state levels. Unlike a dental assistant
who can “clean” above the gumline, a dental hygienist is licensed to “clean” below the
gumline. This is a non-surgical procedure called scaling and root planing (SRP) and is
typically done with local anesthetic to ensure patient comfort. Equally important is the
role of empowering the patient in the care of their oral cavity as it relates to the overall
health of their body and enrolling them in regularly scheduled periodontal maintenance
therapy following scaling and root planing. Patient compliance with periodontal
maintenance therapy is imperative in keeping periodontal disease controlled.
Periodontal Therapy and Glycemic Control. Many studies address the effect of
periodontal therapy on glycemic control. For example, Simpson et al., (2015) conducted a
Systemic Review of the literature to investigate the effect of periodontal therapy on
glycemic control in people with DM2. This review of existing clinical trials conducted
through December 2014 was carried out by the authors working with the Cochran Oral
Health Group and updates the previous version published in 2010. The authors propose
two broad comparisons: 1) Periodontal therapy (SRP) versus usual care/no active
intervention and 2) SRP versus alternative therapy. The authors conclude from 14 trials
(n= 1499) SRP reduces HbA1c in patients with DM2 by 0.29% up to 4 months when
compared with no active intervention/usual care. And after 6 months (five studies (n=
826) there was no evidence this reduction was sustained. The researchers found from 21
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studies (n= 920), no evidence that one periodontal therapy was more effective than
another in improving HBA1c in individuals with DM2. Due to the limitations of the
studies included in this review, the authors call for randomized clinical trials (RCTs) with
larger number of participants and longer follow-up periods. In addition to RCTs, the
authors call for future research to determine whether adjunctive drug therapies should be
used with periodontal treatment.
Similar research was conducted in 2017 by Mauri-Obradors et al. A 6-month
single-masked, randomized clinical trial was undertaken to evaluate the effect of nonsurgical periodontal treatment on HbA1c levels in patients with DM2. A total of 90
subjects with HbA1c levels 7.7% with generalized chronic periodontitis were randomly
assigned to a treatment group (n= 42) or a control group (n= 48). The treatment group
(n= 42) received oral hygiene instruction plus subgingival (below the gumline) nonsurgical removal of dental plaque and calculus (scaling and root planing). The control
group (n= 48) received oral hygiene instruction plus supragingival (above the gumline)
removal of dental plaque and calculus. The findings report an improved periodontal
status and significant improvement (p< 0.05) in HbA1c control 6-months after nonsurgical periodontal treatment, while the periodontal status and HbA1c control in the
control group remained unchanged. The researchers call for future randomized clinical
trials with longer term follow-up and larger number of participants to confirm the current
evidence.
Perhaps the most powerful evidence supporting the hypothesis that periodontal
therapy reduces HbA1c comes from a study conducted by Merchant et al., (2016).
Unique to this study is the number of participants (n=126,805) and the follow-up period
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of 1.7 years. The purpose of this research was to evaluate the impact of long-term
treatment of periodontal disease on glycemic control in a large cohort of individuals
(n=126,805) with DM2 receiving care at Veterans Administration medical centers in the
United States from 2005 through 2012. The exposures were periodontal treatment at
baseline and at follow-up maintenance appointments. The outcome was change in HbA1c
following initial and follow-up treatment. Diabetes control was defined as HbA1c at <7%
and <9% following initial and follow-up treatment. Results from this study indicate that
long term periodontal therapy reduces HbA1c (-0.25%) and increases the probability of
controlling diabetes by 13% at both HbA1c <7% and HbA1c <9% cutoffs. At the same
time, the benefits of periodontal treatment are greater in this group of individuals
compared to those with lower HbA1c levels at baseline (p<0.05). This finding is
clinically meaningful because even a 1% reduction in HbA1c has been shown to reduce
diabetes complications. The United Kingdom Prospective Diabetes Study (UKPDS) data
shows for each 1% reduction in HbA1c, the relative risk for diabetes-related deaths
decreases by 21% (p<0.0001), microvascular complications decrease by 37% (p<0.0001),
and myocardial infarction decreases by 14% (p<0.0001) (Stratton et al., 2000).
On the contrary, in a 6-month randomized clinical trial, Mizumo et al., (2017),
investigated the effects of SRP on HbA1c, oxidative stress balance and quality of life
(QoL) in patients with DM2 compared to no periodontal treatment. Participants with both
DM2 and chronic periodontitis were assigned to a treatment group or a control group.
The treatment group (n=20) received SRP plus oral hygiene instruction (OHI) and
consecutive periodontal maintenance therapy at 3 and 6 months. The control group
(n=17) received only OHI without treatment during the 6-month experimental period.
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The primary study outcome was the change in HbA1c levels form baseline to 3 months.
Secondary outcomes included changes in oxidative stress balance (Oxidative-INDEX),
the Diabetes Therapy-Related QoL, and clinical periodontal parameters from baseline to
3 month and baseline to 6 months. The authors conclude that SRP improves systemic
oxidative stress balance and QoL and results show a modest but not significant reduction
in HbA1c levels (p=0.070). The researchers discuss how improvements in periodontitis
may contribute to better QoL for individuals with diabetes. They report QoL scores
(satisfaction with diabetes treatment) improved after periodontal treatment and suggest
this may contribute to compliance.
The successful treatment of periodontitis reduces inflammation which,
theoretically, could influence HbA1c in individuals with poorly controlled DM2. Based
on this information, controlling periodontal infection plays an essential role in the overall
management of DM2.
The Oral-Systemic Link
The oral-systemic link is the connection between oral health and overall health.
The concept of the oral-systemic relationship has evolved over the years. As far back as
the Middle Ages, the oral cavity was repeatedly implicated as the origin of human
illnesses and diseases. It was suspected an inter-relationship existed between oral disease
and systemic conditions (Genco & Williams, 2010). The literature demonstrates
increasing evidence regarding the relationship between oral disease and systemic diseases
such as diabetes and cardiovascular disease (Lamster, Lalla, Borgakke, & Taylor, 2008;
DeRossi, 2012; Joseph, Kullman, & Sharma, 2016; Cardoso, Reis, & ManzanaresCespedes, 2018). As early as 1998, research conducted by Grossi and Genco
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demonstrates this bidirectional relationship, suggesting diabetes affects periodontal
disease and vice versa (see Figure 8).
Figure 8
Proposed Bidirectional Relationship

Adapted from https://doi.org/10.1902/annals.1998.3.1.51
Early research conducted by Shlossman, Knowler, Pettit, and Genco (1990)
studied the relationship between periodontitis and diabetes and laid the groundwork for
future studies to investigate whether diabetes is a risk factor for developing periodontal
disease. A landmark study by Taylor, Burt, Becker, Genco, & Shlossman (1996) found
patients with DM2 and periodontitis were more likely to develop difficulties in
maintaining a healthy HbA1c than diabetic patients without periodontitis. The
bidirectional relationship is further established in a cross-sectional study involving 40
subjects aged 35-45 years with DM2 and periodontitis, conducted by Tandon et al.,
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(2015). These findings demonstrate an increased prevalence and severity of periodontitis
in individuals with uncontrolled HbA1c. The researchers speculate the “poorer the
control and longer the duration of diabetes, the greater will be the prevalence and severity
of periodontal disease” (p. 300). This concept was also explored by Fatima et al. (2017),
who assessed the effect of uncontrolled diabetes on the health of the periodontium and
concluded the bidirectional relationship between periodontitis and diabetes can be
“explained in terms of glycemic control and severity of periodontitis” (p. 292).
Additionally, Tsau, Hayes, and Taylor (2002), investigated the association between
HbA1c and periodontitis in patients (N= 4,343) between the ages of 45 and 90. After
controlling for age, education, smoking status, and calculus, the authors conclude that
individuals with HbA1c > 9% had a significantly higher prevalence of severe
periodontitis than those without diabetes (odds ratio = 2.90; 95% CI: 1.40, 6.03). It was
also noted the pervasiveness of DM2 with periodontitis was nearly twice that of patients
without periodontitis. It is becoming increasingly clear that oral infection has a systemic
effect. The bacteria within the infected gingiva (periodontal pocket) are disease causing,
highly inflammatory, and able to survive in the blood stream and, thus, intensify
inflammation in other areas of the body (Poudel et al., 2018).
Subsequent studies explore the relationship between periodontal disease and
diabetes to further investigate the bidirectional link (Preshaw, et al., 2012; Casanova,
Hughes, & Preshaw, 2014; Molina et al., 2016; Dogan, Dede, Balli, & Sertoglu 2016).
The mechanisms linking these entities is not fully understood; however, emerging
evidence suggests inflammation may be the basis of this connection.
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Fundamental Linkage. Periodontitis and DM2 each exhibit increased
inflammatory response involving similar biological mediators called cytokines. The role
of cytokines is cell to cell communication. DM2 can increase the activity of inflammatory
mediators within areas affected by periodontal disease. Bacterial invasion of the gingiva,
as seen in periodontitis, stimulates the formation of inflammatory mediators such as
interleukin-1 (IL-1), interleukin-6 (Il-6), tissue necrosis factor-a (TNF-a), and
prostaglandins. These inflammatory mediators lead to the production and activation of
enzymes that destroy gingival connective tissue and destroy bone (Bozhurt, et al., 2016).
With persistent hyperglycemia, as seen in DM2, advanced-glycated end-products are
produced, resulting in the production and release of reactive oxygen species and
proinflammatory mediators such as IL-1, IL-6, and TNF-a. These stimulate an
exaggerated inflammatory reaction, resulting in periodontal tissue destruction with
limited tissue repair (Sabharwal, Gomes-Filho, Stellrecht, & Scannapieco, 2018).
This connection is further substantiated in a review of the literature conducted by
Cardoso, Reis, & Manzanares-Cespedes (2018), focusing on inflammatory cytokines
present in uncontrolled DM2 and chronic periodontitis. The results of this study reveal
both diseases exhibit an overproduction of proinflammatory mediators, such as IL-1, IL6, and TNF-a suggesting a “fundamental linkage” (101). The authors conclude the
overproduction of proinflammatory cytokines exacerbates the destruction of the
supporting soft and hard tissue surrounding the teeth.
Consistent with this finding, in a case-control study conducted by Mesia et al.,
(2016), participants (N=20) with moderate to severe periodontal disease were divided
equally into two groups: those with DM2 and those without. The purpose of this study
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was to quantify immune responsiveness in individuals with and without DM2. Although
this study did not directly evaluate inflammation, the results demonstrated higher levels
of IL-1, IL-6, and TNF-a in the group with moderate periodontitis and DM2 (see Figure
9).
Figure 9
Proposed Fundamental Linkage

Note. Periodontitis and uncontrolled DM2 are inflammation-driven, thus contributing to
the destruction of the hard and soft tissues of the periodontium.
Perhaps the most convincing evidence of the fundamental linkage comes from a
review of the literature conducted by Polak and Shapira (2018). The purpose of this
review is to evaluate current evidence of the mechanism that may link periodontitis and
diabetes. The study is based on a review conducted by Taylor et al., (2013) with the
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addition of research from June, 2012, through November, 2016. This search resulted in
831 publications. Title screening resulted in 256 articles with relevant topics. Abstract
screening (excluding pregnancy diabetes articles) resulted in 35 reviews, 40 animal
studies, and 99 human studies. Studies were screened and evaluated according to the
level of diabetes control, as defined in each study. The results were divided according to
the following scientific topics: 1) Biological plausibility (proposal of a causal
relationship) of increase in severity of periodontitis in patients with diabetes 2) Biological
plausibility of the effect of periodontitis on diabetes control, and 3) Biological
plausibility of the effect of treatment of periodontitis on diabetes control. The results of
this study indicate a possible association between HbA1c and changes in the periodontal
bacteria, with no causal relationships. Clinical and animal studies found elevated gingival
levels of IL-1, IL-6, TNF-a in poorly controlled diabetes and individuals with diabetes
and periodontitis exhibit high-levels of circulating TNF-a. In addition, successful
periodontal treatment reduces their levels.
The authors conclude poorly controlled HbA1c levels may aggravate
periodontitis. Some evidence suggests the systemic inflammation, resulting from
periodontitis, has the potential to affect diabetes control. However, they found no studies
addressed the impact of successful periodontal therapy on the mechanisms involved in
systemic complications of diabetes.
Conversely, Taylor, Preshaw, & Lalla (2013), in a review of the evidence for
pathogenic mechanisms that may link periodontitis and diabetes, explore the roles of
cytokines and metabolic molecules (glucose and lipids) and periodontal bacteria. They
conclude although diabetes results in metabolic dysregulation, hyperglycemia, and
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chronic inflammation impacting tissue integrity and repair, the periodontal microbiota
appears unaltered by diabetes and there is little evidence it may influence glycemic
control. The authors postulate the role of proinflammatory factors remains speculative
and call for future longitudinal clinical studies using larger patient groups, integrated with
studies of animal models and cells/tissues in vitro.
Both diabetes and periodontal disease are inflammation driven. Because of this,
controlling inflammation is paramount in managing both diseases. The successful
treatment of periodontal disease, performed by an RDH, reduces inflammation and
therefore could help control HbA1c. In the same way, controlling HbA1c, under the
guidance of a CDCES, could contribute to reduced inflammation in the gingiva.
Interprofessional collaboration is needed to support interdisciplinary treatment in
controlling inflammation associated with these two diseases.
Certified Diabetes Care Education Specialists (CDCES)
Individuals with diabetes learn to manage their disease through diabetes selfmanagement training or diabetes education in a collaborative process led by diabetes
educators. A CDCES is a healthcare professional who has met eligibility requirements
and passed a rigorous exam to become certified. Prior to 2020 these healthcare
professionals were known as Certified Diabetes Educators or CDE. For purposes of
clarity, this literature review uses the CDCES when referring to the former CDE. The
National Certification Board for Diabetes Educators (NCBDE) and the CDCES credential
were established in 1986 and are considered the standard of excellence for quality
education and certification for those providing direct care to individuals with diabetes.
Prior to taking the certification exam, professional experience working in the diabetes
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education field is required. To maintain this credential, CDCES are required to stay up to
date on the latest in prediabetes and diabetes care by obtaining a specific amount of
continuing education credits. The NCBDE (2019) list the following eligibility
requirements that must be met prior to testing:
A. Bachelor’s degree at a minimum and current, active, and unrestricted licensure
B. Registration /Certificates
o Dietitian or dietitian nutritionists holding active registration with the
Commission on Dietetic Registration
o Physician Assistant holding active certification with the National
Commission on Certification of Physician Assistants
o Exercise physiologist holding active certification as an American College
of Sports Medicine Certified Clinical Exercise Physiologist
o Health educator holding active certification as a Master Certified Health
Education Specialist from the National Commission for Health Education
Credentialing
C. Health care professionals with a minimum of a master’s degree in social work
from a United States college or university accredited by a nationally
recognized regional accrediting body.
1. Professional Practice Experience (after meeting the Discipline Requirement)
A. Minimum of 2 years of professional practice experience in the discipline
under which the individual is applying for certification
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B. Minimum of 1,000 hours of diabetes education experience earned within 4
years of application date, with a minimum of 40% of those hours occurred in
the most recent year preceding application.
2. Continuing Education
A. A minimum of 15 clock hours of continuing education (CE) activities
applicable to diabetes is required prior to sitting for the exam. The CE must be
earned and approved by a provider on the NCBDE List of Recognized
Providers
The three most common healthcare providers to hold the CDCES credential are
nurses (49%), registered dieticians (41%), and pharmacists (7%). CDCES work in varied
settings, including hospitals, clinics, small practices, wellness centers, pharmacies, and
for diabetes technology and medical device companies (Massey, 2019). The role of the
CDCES can vary depending on the work environment. CDCES possess comprehensive
knowledge of and experience in diabetes prevention, prediabetes, and diabetes
management. They educate, support, and advocate for people affected by diabetes. The
CDCES promotes self-management to achieve individual behavior and treatment goals
that reduce risks and optimize health outcomes. They address the unique aspects of the
individual’s life that impact diabetes care such as adjustments in diet, physical activity,
blood glucose monitoring, medication dosing, and stress management (ADA, 2019).
Therefore, CDCES are positioned to partner with other healthcare professionals in
providing total patient care for the diabetic patient.
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Barriers to Interprofessional Collaboration
Lopes, Southerland, Buse, Malone, and Wilder (2012) conducted a qualitative
study to identify the knowledge, opinions, and behaviors of CDCES (n=298). A 33-item
questionnaire, consisting of open and close-ended and Likert-scale, was used to gather
data. It was determined that of participating CDCES, 62% recognize the need for
collaboration with dental professionals and 64% referred a patient to the dentist in the last
year; 79% have not received formal oral health education, while 84% are interested in an
oral health component in continuing education; 51% discussed oral health with their
patients; and 20% felt confident in providing oral health screening to their patients. The
authors call for further studies to determine the most effective method to educate CDCES
about periodontal disease and diabetes and to determine if increased oral health
information impacts their patients.
Similarly, a systemic search of five data bases was undertaken by Poudel,
Griffiths, Wong, Arora, and George (2017) to provide a snapshot of the role of diabetes
care providers and non-dental professionals in oral health care and management of
individuals with diabetes. Relevant studies published through October 2016 were
included (n=30) with no restrictions on the study design, quality, or setting. The focus of
this study was to examine evidence on the knowledge and practices of diabetes care
providers in oral healthcare/management of individuals with diabetes and to examine the
role of non-dental professionals in oral health promotion. The results of this review
determine diabetes care providers are not addressing oral health due to time constraints
and limited oral health knowledge. The researchers call for future studies to identify
barriers and resources to support diabetes educators in promoting oral health.
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Additionally, a qualitative study was conducted by Bissett, Stone, Ripley, and
Preshaw (2013) to explore knowledge and attitudes regarding the links between diabetes
and periodontitis of medical and dental healthcare professions as well as those of
individuals with diabetes. Participants in this study included individuals with diabetes
(n=4), dental professionals (n=4), general practitioners (GP) with a specialist interest in
diabetes (n=3), GP without a special interest in diabetes (n=1), diabetic nurse specialists
(n=3), and consultant diabetologists (n=2). Four inter-related themes relative to
knowledge emerged from this study: 1) Uncertain knowledge regarding the links between
periodontitis and diabetes 2) Unworkable knowledge regarding the differing medical and
dental operating systems the healthcare professionals work in 3) Isolated knowledge or
the perceived division that exists between medical and dental professions that could
negatively impact advances in diabetes care and 4) The patient simply wanted the same
consistent message from healthcare providers and help accessing dental care as needed.
The authors call for future research to identify barriers to interprofessional collaborative
care and to establish effective ways to implement change.
Summary
Diabetes and periodontal disease are inflammation driven diseases. They are
common and complex conditions. The relationship between diabetes and periodontal
disease may be explained in terms of glycemic control and the severity of periodontal
disease, and the inference can be made individuals with diabetes are likely to have
periodontal disease and vice versa. Researchers agree additional studies are needed to
further understand the mechanisms linking these two conditions. Emerging evidence
supports the concept that periodontal infection adversely affects glycemic control and
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poor glycemic control affects the periodontium; however, future randomized clinical
trials employing robust methods with longer term follow-up and larger number of
participants are needed to confirm and strengthen the current evidence. Researchers
conclude, future studies are needed to evaluate substantiated periodontal therapies
regarding DM2 and HbA1c. They also call for future studies to identify the barriers and
possible oral health resources needed to support the CDCES in partnering with dental
professionals to provide total patient care.
Periodontal therapy may help reduce and control glycemic levels. Similarly,
improved glycemic control may help improve periodontal disease. Glycemic control
(HbA1c) is potentially impacted by periodontitis, increasing the risks of other diabetic
complications, thus, it is important to include the treatment of periodontal disease as an
integral element of diabetes care.
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Methodology
Research Method or Design
This pilot study looked at a point of care Periodontal Screening Tool to evaluate
and promote periodontal care. This was a descriptive study with an exploratory design.
A mixed methods approach gathered qualitative and quantitative data. The quantitative
design allowed for the reporting of frequencies, averages, and percentages and the
qualitative method determined opinions and attitudes. A demographic survey, pre-test,
post-test, Education and Training Module, and Periodontal Screening Tool were used to
answer the following questions: 1) Did a Periodontal Screening Tool, accompanied by
training on how to use this tool, increase CDCES’s confidence in informing the patients
on periodontal disease risk factors? and 2) Did the CDCES’s confidence result in
providing resources for their patient to seek dental care?
Procedures
Human Subjects’ Protection/Informed Consent
The Eastern Washington University (EWU) Institutional Review Board (IRB)
approved this research. Participating educators signed consent (see Appendix A) prior to
completing a pre-test (see Appendix B). CDCES from Kootenai Health, Coeur d’Alene,
Idaho, and Providence Medical, Spokane, Washington, participated.
Participant consent and pre-test were emailed to the Kootenai Health Diabetes
Care Coordinator for distribution to Kootenai Health CDCES. Signed consent forms and
completed pre-tests were electronically returned to the PI. At the conclusion of this study
participants completed a post-test (see Appendix E) delivered via the participant’s email
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and electronically returned to the PI, while CDCES from Providence Medical were sent a
link for SurveyMonkey via their email to access participant consent and pre-test. At the
conclusion of this study, a SurveyMonkey link was provided to access the post-test.
Participation in this study was voluntary and participants could withdraw at any
time. Any risks associated with this study were minimal and did not exceed those
encountered in daily life. It is unlikely the CDCES received direct benefits from their
participation in this study. All data collected from the pre- and post-tests and completed
Periodontal Screening Tools was kept confidential on a password protected personal
computer that only the PI (student) had access to and was shared only with the
statistician. The participant’s personal information from this study remains confidential.
At the completion of the study, the hard copies were scanned onto a thumb drive and will
be kept in a safe, at the PI’s residence, for five years. After the thesis defense, the hard
copies were shredded and disposed.
Sample source, plan, sample size, description of setting.
For pragmatic purposes, CDCES currently employed by Kootenai Health and
Providence Medical were invited to participate in this study. As an incentive, participants
were entered in a drawing for a Sonicare Toothbrush. This study coincided with diabetes
counseling sessions provided in the clinical setting at Kootenai Health and Providence
Sacred Heart Medical Center. Kootenai Health employs three CDCES, of which all three
chose to participate. On a weekly rotation, due to COVID restrictions, two of three
CDCES work remotely, while the third works in the Diabetes and Endocrinology clinical
setting. Providence Medical employs three CDCES who work in several locations. One
CDCES working in the clinical setting at Diabetes and Endocrinology in Providence
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Sacred Heart Medical Center was recruited and chose to participate. The duration of this
study was two weeks.
Sample size for the qualitative data was determined by the number of CDCES
who enrolled in the study. For quantitative data gathering, the number of times the
CDCES completed the Periodontal Screening Tool and provided the resource list for the
patient to seek a dental provider during the two-week study was tracked. Given that four
CDCES see approximately 100 patients per month, with a 50% response rate, a 5%
margin of error, and 95% confidence level, 66 completed Screening Tools was needed for
statistical significance.
This study was conducted in person using a hard copy Periodontal Screening Tool
and patient demographic survey. The hard copy was chosen because it did not become
part of the patient’s medical record and for ease of use; thus, the potential for a greater
response.
Variables
The independent variable was the Periodontal Screening Tool developed by the PI
as an assessment tool for periodontal disease risk factors. The dependent variables were
the CDCES’s confidence in informing their patients on periodontal disease risk factors
and the number of times the CDCESs provided dental care resources to their patients.
These were measured via post-test at the conclusion of the study period.
Instruments
The instruments used for this pilot study were developed by the PI and include:
Periodontal Screening Tool, pre-test, post-test, and an on-line Education and Training
Module.
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The Periodontal Screening Tool was developed as a periodontal risk factor tool
for CDCES to use and includes a demographic survey to gather data regarding the
patient’s dental history, a list of risk factors, a decision tree for recommending dental care
as well as a resource list for the patient (see Appendix D). Based on research, several
factors contribute to periodontal disease, including, but not limited to, poor oral hygiene,
genetic susceptibility, medications, smoking, and systemic diseases. Content validity was
achieved by using evidence-based resources for determining risk factors and reviewed by
seasoned practitioners. The PI formulated the questions that could be easily answered
with yes or no and were appropriate for the diabetic patient. This instrument contained no
patient identifiers and was limited to seven questions to ensure utility and frequency of
use. It was delivered by the PI as hard copy to the CDCES.
The pre-test consisted of a survey designed to gather CDCES demographic
information and Likert-type questions to measure the current confidence level in
informing their patients on periodontal risk factors and recommending dental care (see
Appendix B). The post-test included the same Likert-type questions as the pre-test, with
the addition of open-ended and close-ended questions and was designed to measure the
perceived effectiveness of the Periodontal Screening Tool. A Likert scale numbered 1-5
in equal intervals was used to rank confidence levels. Number 1 represented not at all
confident and 5 represented extremely confident (see Appendix E). The pre- and posttests were designed to be accessed online as well as hand delivered.
The Education and Training Module was created as an orientation to the
periodontal diabetes link and periodontal risk factors. It also provided instruction for
using the Periodontal Screening Tool. Information used in this module was founded on
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evidence-based research and reviewed by the thesis committee. This module consisted of
a 26 slide PowerPoint lecture and was delivered via Zoom prior to using the tool (see
Appendix C).
Equipment
Minimal equipment was used for this study. CDCES used their work computer or
personal computers to access the surveys and to participate in the Zoom conference for
the Education and Training Module.
Steps to Implementation
The following steps were completed for this study upon EWU IRB approval.
Step 1. Enrollment. The PI communicated with the Diabetes Care Coordinators
at Kootenai Health and Providence Medical to generate interest and discuss enrolling
CDCES in the study.
Step 2. Consent and Pre-test. Once interest was established, the Participant
Consent Document and Pre-test Survey were emailed to the participants through
SurveyMonkey. SurveyMonkey uses two methods for tracking responses: through
SurveyMonkey using participant’s email address or through a shared link. Because three
participants were from Kootenai Health and the PI needed to compare pre- and post-test,
tracking responses based on email address was used. Due to technical security measures
associated with Kootenai Health and Providence Medical the invite from SurveyMonkey
was not delivered. As an alternative method the PI emailed the Participant Consent
document and Pre-test Survey to the Kootenai Health Diabetes Care Coordinator, who
then printed and distributed them to the CDCES. Those who elected to participate signed
consent (see Appendix A) and completed a Demographic Survey and pre-test (see
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Appendix B) that was electronically returned to the PI. Because there was only one
participant from Providence Medical, the PI directly emailed the shared SurveyMonkey
link.
Step 3. Education and Training Module. Participants attended the required
Education and Training Module (see Appendix C) via Zoom prior to using the
Periodontal Screening Tool (see Appendix D).
Step 4. Data Gathering. The hard copy, one-page, Periodontal Screening Tool
was hand delivered to the CDCES at the Diabetes and Endocrinology Clinics at Kootenai
Health and Providence Sacred Heart Medical Center. The Periodontal Screening Tool
was used as an adjunct to counseling. If there were any “yes” answers for periodontal risk
factors in the first section of the one-page Screening Tool, the CDCES completed the
Patient Survey in the second section to determine if the patient has a dental home and if
not, off the tear-off resource list provided. Completed Periodontal Screening Tools were
kept in a designated folder and stored in a sealed envelope for weekly pick-up by the PI.
Step 5. Post-test. A post-test (see Appendix E), designed to evaluate the
perceived effectiveness of the Periodontal Screening Tool, was sent via the participant’s
email following two weeks of data collection. The completed post-test was electronically
returned to the PI.
Step 6. Data Analysis and Management. The PI collected the completed
Periodontal Screening Tools weekly. Data from the Periodontal Screening Tool, pre- and
post-tests, and demographics were entered into a Microsoft Excel worksheet for analysis.
The online platform provided ease of access for data collection and analysis. All data
collected from the pre- and post-tests and Periodontal Screening Tools was kept

PERIODONTAL RISK FACTOR EVALUATION TOOL

37

confidential on the PI’s personal password protected computer and only the PI and a
statistician had access to the information. The identity of all participants remains
confidential. At the completion of the study, the hard copies were scanned onto a thumb
drive and will be kept in a safe at the PI’s residence for five years. Hard copies were
shredded and disposed of. All data was kept on a password protected computer that only
the PI had access to.
Summary
Individuals with uncontrolled diabetes are likely to have periodontal disease and
vice versa. For this reason, collaboration between medical and dental professionals is
essential in the care and treatment of the diabetic patient. Providing a Periodontal
Screening Tool together with an Education and Training Module as an orientation to the
periodontal diabetes link and introducing periodontal risk factors, could increase
confidence among CDCES in informing their patients on periodontal risk factors and
recommending dental care. Introducing a Screening Tool for periodontal disease risk
factors for non-dental professionals could translate to individuals with poorly controlled
diabetes seeing the dentist or dental hygienist for evaluation and treatment.
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Results
The aim of the study was to determine the effect of using a Periodontal Screening
Tool on CDCES’s confidence in informing their patients on periodontal risk factors and
providing resources for the patient to seek dental care.
Description of Sample
For pragmatic purposes, CDCES employed by Kootenai Health and Providence
Medical were recruited to participate in this research. The results gathered from a
convenience sample of CDCES were used to determine if using a Periodontal Screening
Tool, accompanied by a training on how to use the tool, increases the CDCES’s
confidence in informing their patients on periodontal disease risk factors and results in
providing resources for the patient to seek dental dare. Kootenai Health Diabetes and
Endocrinology employs three CDCES, of which all consented to participate. One CDCES
working at Diabetes and Endocrinology at Providence Sacred Heart Medical Center also
consented to participate.
A total of four (n=4) participants completed this study. Based on demographic
questions, two participants are between the ages of 25 and 34 years of age, one
participant is between 45 and 54 years old, and one participant is between 55 and 64
years old. All participants are female and in addition to being CDCES, they are
Registered Dietitians. All participants practice in a specialty office and three also work in

PERIODONTAL RISK FACTOR EVALUATION TOOL

39

the hospital setting. Two participants have been providing counseling between 6 and 10
years while the other two have been providing counseling between 21and 25 years. The
number of hours per week providing services was equally split between 16 to 20 hours
and 26 hours or more. A summary of demographic data is provided in Table 3.
Table 3
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Statistical Analysis
After completing the pre-test, the CDCES participated in an Education and
Training Module on the oral-systemic link between diabetes and periodontal disease,
periodontal disease risk factors, and use of the Periodontal Screening Tool. After using
the Periodontal Screening Tool for two weeks, the CDCES completed the post-test,
which was identical to the pre-test with the addition of three close-ended and two openended questions. The number of times the CDCES completed the Periodontal Screening
Tool and number of times they provided the resource list for the patient to seek a dental
provider during the two-week study period were tracked. Given that 88 patients were
seen in two weeks, with a 50% response rate, a 5% margin of error, and 95% confidence
level, 33 completed Periodontal Screening Tools were needed for statistical significance.
A total of 88 patients were seen during the two-week study period and the Periodontal
Screening Tool was used 26 times (29.5%). Of the 26 completed Periodontal Screening
Tools, a total of 5 resource lists (19%) were given to the client. Therefore, the power of
this study fell below the optimal power needed to achieve significance.
First research question
To answer the research question, Did a Periodontal Screening Tool accompanied
by training on how to use this tool increase CDCES’s confidence in informing the
patients on periodontal disease risk factors, a paired two tailed t-test was used to
compare the pre- and post-test data.
For the pre- and post-test this study found a p-value of 0.15 using a paired two
sample t-test. This means the probability of random error is .15 or 15%. Thus, the
probability that the intervention caused the change in the pre- and post-tests is 85%. A
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95% C.I. for the difference between the pre- and post-test means is (-2.032), (8.032). The
probability the intervention caused the change between the pre- and post-test is not
significant; however, because the p-value is 0.15, a greater sample size has the potential
to increase the power to a point where significance is attained. Thus, the findings of this
study likely have created a Type 2 Error, meaning a significance was not achieved where
significance may exist. Table 4 shows the inferential statistics for the means of the preand post-tests.
Table 4
Average Likert-scale Comparison
pre
Mean
Standard Error

post
15.75
1.75

Mean
Standard Error

difference
18.75
1.38

Mean
Standard Error

3
1.58

Standard
Deviation

3.5

Standard
Deviation

2.75

Standard
Deviation

3.16

Sample
Variance
Maximum

12.25
20

Sample
Variance
Maximum

7.583
22

Sample
Variance
Maximum

10
6

Count

4

Confidence
Level (95.0%)
CI 95% Below

5.57
10.18

CI 95% Above

21.32

Count
Confidence
Level (95.0%)

Descriptive statistics for pre- and post-test

4
4.38
14.37
23.13

Count
Confidence
Level (95.0%)

4
5.03
-2.03
8.03

A Pearson Correlation was done for the pre- and post-tests. The r = 0.51 indicates
that the correlation is moderate and positive. With a larger sample size, this correlation is
likely to change dramatically. The correlation r-value and p-value for pre- and post-test
are provided in Table 5.
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Table 5
t-Test: Paired Two Sample for Means

Mean
Variance
Observations
Pearson Correlation
t Stat
P(T<=t) two-tail

pre

post

15.75
12.25
4
0.51
-1.9

18.75
7.58
4

0.15

Significance was set at the p-value < 0.05.
Likert-scale data from five questions, as well as qualitative data from three yes/no
questions and two open-ended questions, were gathered and analyzed. Table 6 shows
whether the change in pre- and post-test scores was a result of the Periodontal Screening
Tool or random error. The p-value indicates the probability that the change was the result
of the Periodontal Screening Tool or random error. A low p-value indicates there is a
strong probability the difference noted was the result of the Periodontal Screening Tool
accompanied by Education and Training Module rather than random error. A correlation
is the ability to predict one score based on another.
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Pre-test and Post-test Likert-scale Questions
________________________________________________________________________
Survey Question
Response
Paired two tailed
Pearson Correlation
difference
t-test p-value = 0.15
r-value = 0.51
Q1 How confident are you
counseling the patient
about oral health

4 points

.092

.150

Q2 How confident are you
in your knowledge about
periodontal disease

2 points

.182

.818

Q3 How confident are you
in your knowledge of the
bidirectional relationship
between diabetes and
periodontal disease

2 points

.182

.333

Q4 How confident are you
in educating the patient
about periodontal disease

2 points

.495

.000

2 points

.182

.818

Q5 How confident are you
recommending the patient
see the dentist or dental
hygienist for a periodontal
evaluation
Note. p-value = 0.05

Note. r-value no correlation = .000, correlation ± .001 to .300 = weak,
± .301 to .700 = moderate, ± .701 to 1.000 = strong
The following provides further explanation per the initial five questions: Q1, Q2,
Q3, Q4, and Q5 on the pre-test and post-test per item analysis.
Q1 The paired two tailed t-test p-value is .092. Thus, there is a high probability (91%) the
change noted is the result of the Periodontal Screening Tool rather than random error.
The Pearson Correlation r-value is .150, indicating a weak correlation.
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Q2 The paired two tailed t-test p-value is .182. Thus, there is an 82% probability the
change noted is a result of the Periodontal Screening Tool rather than random error. The
Pearson Correlation r-value is .818, indicating a strong correlation.
Q3 The paired two tailed t-test p-value is .182. Thus, there is an 82% probability the
change noted is a result of the Periodontal Screening Tool rather than random error. The
Pearson Correlation r-value is .333, indicating a moderate correlation.
Q4 The paired two tailed t-test p-value is .495. There is a 50% probability that the change
noted was not the result of the intervention, meaning there is strong probability it was due
to random error. The Pearson Correlation r-value is .000, therefore, no correlation exists.
Q5 The paired two tailed t-test p-value is .182. Thus, there is an 82% probability the
change noted is a result of the Periodontal Screening Tool rather than random error. The
Pearson Correlation r-value is .818, indicating a strong correlation.
The post-test included three close-ended questions, Q6, Q7, and Q8, as well as
two open-ended questions, Q9 and Q10. All CDCES reported using the Periodontal
Screening Tool increased their confidence in recommending patient for dental care. They
also reported training on the use of the Periodontal Screening tool was adequate. Fifty
percent of the CDCES would be likely to implement a periodontal risk factor evaluation
tool into their practices. Table 7 provides the responses to the close-ended questions.
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Table 7

Responses to Close-ended Questions
________________________________________________________________________
Survey Question
Yes No
%
Q6. Did using the Periodontal Screening
Tool increase your confidence in
recommending patient for dental treatment?

4

0

100

Q7. Was training on the use of the Periodontal
Screening Tool adequate?

4

0

100

Q8. Would you be likely to implement a
periodontal risk factor evaluation tool
such as the Periodontal Screening Tool
into your practice?
Note. (N=4)

2

2

50

The qualitative data gathered from the two open-ended questions, Q9 and Q10,
was evaluated with content and narrative analysis focusing on themes that were
frequently present in CDCES’s answers.
When asked, What about the Periodontal Screening Tool was helpful, 50%
reported it opened the conversation and provided a segue into discussing oral health, 25%
reported ease of use and resources provided, while 25% reported it was a useful reminder.
When asked for suggestions on what they thought would make the Periodontal Screening
Tool stronger, 25% suggested a shorter version, 25% replied “some of the questions
could be clearer,” 25% suggested more resources, and 25% felt it was very strong and
had no suggestions. Figure 10 provides the CDCES’s responses to the open-ended
questions in the post-test.
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Figure 10
Responses to Open-ended Questions
Q9. What about the Periodontal
Screening Tool was helpful?
“Was a great icebreaker for patients and
easy segue into speaking about oral
health.”

Q10. What addition(s) to the
Periodontal Screening Tool would
make it stronger?
“I would actually make it a little shorter.”

“It was easy to use. I like the resources
provided.”

“More resources”

“It opened the conversation to care
guidelines, the client's regimen/care, and
resources.”

“It seems very strong, I don't have any
suggestions.”

“Mostly as a reminder”

“Some of the questions could be clearer.”

Note. Respondents’ full answers in quotes (N=4)
Second research question
To answer the research question, Did the CDCES’s confidence result in providing
resources for their patient to seek dental care, descriptive statistics were used. Data
gathered from the completed Periodontal Screening Tools (n=26) indicates that several
patients were not at risk for periodontal disease (35%). The patient demographic data
indicated the majority of patients (95%) have a dental home and were not referred by
their medical professional (95%). One patient who did not have a dental home and was
referred by their medical provider, reported they were unable to find a dentist who
would accept Medicaid. Five resource lists were given to the patients to seek dental care
(see Figure 11).
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Figure 11
Completed Periodontal Screening Tool Data

Resource list given
Referred by medical provider
Not referred by medical provider
Need a dental home
Already have a dental home
No periodontal risk factors
0

5

10

15

20

Note. (N=26)
Results from this study demonstrate the use of a Periodontal Screening Tool with
an Education and Training Module resulted in increased confidence in informing the patient
about periodontal disease risk factors and providing resources to seek dental care. A strong
correlation was found between the pre- and post-test scores. One hundred percent of the
CDCES reported using the Periodontal Screening Tool increased their confidence in
recommending patient for dental care. These results indicate the sample size (n=4) is not

large enough to determine statistical significance; however, findings suggest this pilot
study is feasible. These findings are discussed in the following chapter.
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Discussion
Summary of Major Findings
The results of this Pilot Study indicate using a Periodontal Screening Tool,
accompanied by education and training on how to use it, increased the CDCES’
confidence level when informing the patient on periodontal disease risk factors and
resulted in providing resources to seek dental care. Prior to using the Periodontal
Screening tool, the CDCES attended an Education and Training Module focusing on the
periodontal-diabetes link, periodontal risk factors, and instruction for use. During the
two-week study period, CDCES incorporated the Periodontal Screening Tool as an
adjunct to counseling. A total of 88 patients were seen during the study period. There
were 26 completed Periodontal Screening Tools and 5 resource lists given. By comparing
their confidence levels before and after using the Periodontal Screening Tool it was
evident this non-dental screening tool had a positive influence on perceived confidence.
Discussion of these results are organized around the research questions.

Discussion
Research question #1: Did a Periodontal Screening Tool accompanied by training on
how to use this tool, increase CDCES’s confidence in informing the patient on
periodontal disease risk factors?
The results of the pre- and post-test five Likert scale scores on the CDCES’
confidence demonstrate an overall increase in confidence in informing the patients on
periodontal disease risk factors however, areas of improvement exist. There were two
CDCES who have practiced for 25+ years and reported little change between pre-test and
post-test scores. Perhaps this is due to longevity in the workplace and the need for
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Continuing Education (CE) requirements. Several topics for CE are available and could
include periodontal disease and the oral systemic link; therefore, these participants may
have already had knowledge of the correlation between diabetes and periodontal disease.
Regarding Q1, CDCES were confident counseling the patients about oral health
prior to participating in the Education and Training Module and using the Periodontal
Screening Tool. The Pearson Correlation r-value of 0.150 indicates the ability to predict
the post score based on the pre score is weak. There could be several possibilities for why
this relationship was weak. One possibility is CDCES with more experience already
educate patients about the long-term negative consequences of uncontrolled diabetes.
Their training includes oral manifestations associated with diabetes which may account
for their confidence prior to implementing this study.
Findings about confidence from Q2 knowledge of periodontal disease, Q3
bidirectional relationship between diabetes and periodontal disease, and Q5
recommending or referring a patient for a periodontal evaluation show a moderate to
strong correlation between the pre- and post-test and indicate there is an 82% probability
the change noted is a result of using the Periodontal Screening Tool. In the Education and
Training Module the PI informed the CDCES on the diabetes-periodontal disease link
and periodontal disease risk factors in addition to use of the Periodontal Screening Tool.
Two CDCES reported an increase in perceived confidence for Q1, Q2, Q3, Q4, and Q5;
however, combined they used the screening tool seven times and neither one shared the
resource list with the patient. Based on their number of Periodontal Screening Tools
completed, it seems the increase in confidence may have been the result of the Education
and Training Module rather than the experience of using the Periodontal Screening Tool.
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This point is meaningful and speaks to the need for education on the oral systemic link,
the need for more inter-professional education (IPE), and inter-professional collaboration
(IPC).
In contrast, the findings from Q4 regarding confidence in educating the patient
about periodontal disease, indicate the change noted was not the result of the Periodontal
Screening Tool. The results show little change between the pre and post-test scores with
no correlation; meaning, educating the patient on periodontal disease may still be
uncomfortable for CDCES. Developing a Periodontal Education Aid for the CDCES to
use could increase their confidence in doing so. For example, a YouTube link to the
module, a podcast as a review of how to use the Periodontal Screening Tool, a two-sided
laminated diagram with the Periodontal Screening Tool on one side, and graphics,
weblinks, and quick references on the other side for the CDCES.
There were two CDCES who have practiced for 25+ years and reported little
change between pre-test and post-test scores. This may be due to longevity in the
workplace and the need for yearly Continuing Education (CE) requirements. Several
topics for CE are available and could include periodontal disease and the oral systemic
link.
Results from this study showed comparable findings to research conducted by
Lopes, et al., (2012), who found 20% of participating CDCES felt confident in providing

oral health screening to their patients, 51% discussed oral health with their patients, and
64% referred a patient to the dentist in the last year. Furthermore, this study indicates a
need for ongoing education about periodontal disease for CDCES which aligns with
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findings from Poudel, et al., (2017) who identified limited oral health knowledge and the
effect this has on the management of individuals with diabetes.
When answering the three close-ended questions and two open ended questions,
these CDCES reported using the Periodontal Screening Tool increased their confidence
in recommending patient for dental care. They also reported training on the use of the
Periodontal Screening Tool was adequate. When asked which aspects of the Periodontal
Screening Tool were helpful, 50% reported it opened the conversation and provided a
segue into discussing oral health, while 25% reported it was easy to use. The CDCES saw
value in the Periodontal Screening Tool and 50% would be likely to implement a
periodontal risk factor evaluation tool into their practice. This is meaningful because it
indicates they are going to use it and most importantly, it has the potential of benefitting
the patient.
Although this sample size is small for statistical analysis, the qualitative answers
provided helpful recommendations for strengthening the Periodontal Screening Tool.
When asked for suggestions on what would make the Periodontal Screening Tool
stronger, 25% commented that it was strong as it is, while 75% had specific comments
for changes.
It was suggested the Periodontal Screening Tool be shorter, more concise, and
provide more resources. Revising the questions for more clarity in the patient’s dental
history may have provided valuable information regarding the patient’s knowledge about
why it is important to see the dentist when diagnosed with diabetes. For example, the first
question asked was Do you have a dental home followed by If yes, were you referred by
your medical professional. It was interesting to learn most patients (95%) had a dental
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home; however, only one was referred by their medical professional. Perhaps a better
question might have been Did your medical provider inform you about the systemic link
between diabetes and periodontal disease and the need to see the dentist for an
evaluation. Asking the question differently could highlight the need for practitioners to
initiate that conversation and the importance of recommending dental care.
Research question #2: Did the CDCES’s confidence result in providing resources for
the patient(s) to seek dental care?
Five resource lists were given. One CDCES was responsible for 100% of the
resource lists that were shared. She also used the Periodontal Screening Tool 58%
compared to a combined 42% for the other CDCES. It seems the more times the
Periodontal Screening Tool is used, more opportunities are provided for sharing the
resource list.
Compared to total number of patients seen (N = 88), only 26 Periodontal
Screening Tools (n=26) were used. This number seems small due to an assumption that
there would more opportunities to use the Periodontal Screening Tool. This could be a
result of the type of counseling appointment. Patients seen strictly for instruction on
medication and use of the insulin pump were not candidates for using the Periodontal
Screening Tool. A problem with the methodology was not tracking how many
appointments were strictly medication use and insulin pump instruction. Future research
should exclude patients being counselled only for medication use and insulin pump
instruction.
The Periodontal Screening Tool was designed as adjunct to education and training
for the CDCES’s use. It included a demographic survey to gather data regarding the
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patient’s dental history, a decision tree for recommending dental care, and a resource list.
If there were any “yes” answers for periodontal risk factors in the first section of the onepage Periodontal Screening Tool, the CDCES completed the patient survey in the second
section to determine if the patient had a dental home and if not, provide the tear-off
resource list. The results from this survey indicate 6 patients (35%) answered “no” to all
questions in the first section; therefore, the CDCES did not complete the dental history,
thus did not share the resource list. It was assumed by the PI that only individuals with
uncontrolled Type 2 diabetes were referred for counseling. The results of this study
showed individuals with well-controlled blood sugar levels also receive counseling.
The second half of the Periodontal Screening Tool consisted of a patient survey
designed to discover the patient’s dental history, identify possible barriers to care, and
provide resources to seek dental care. Twenty-six Periodontal Screening Tools were
completed and of those, only five resource lists were given. It was assumed that medical
providers who diagnose diabetes do not refer their patients to the dentist for a periodontal
evaluation. It was interesting to learn most patients (95%) had a dental home; however,
they were not referred by their medical professional. A possible reason could be that the
patient had a dental home prior to being diagnosed with diabetes; therefore, they would
not need a referral. One of the questions in the demographic patient survey was If you did
not see the DDS, why not followed by a check list of choices including fear, expense,
pain, unaware of the risks of gum disease, and other. There was one patient (5%) who did
not have a dental home and was referred by their medical provider who answered,
“Medicaid not accepted by most dentists.” From previous research on barriers to care, the
PI was aware that many dentists limit the number of Medicaid patients they accept due to
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the low reimbursement rates. For this reason, the two recommendation for dental care on
the resource list were Eastern Washington University Dental Hygiene Clinic and North
Idaho College Dental Hygiene Clinic, both of which accept Medicaid. When asked what
would make the Periodontal Screening Tool stronger, 25% responded more resources,
which should be considered going forward. Another interesting fact the PI had not
accounted for was edentulous patients with diabetes. In this study, two patients (10%)
wore dentures, which had an effect on the number of resource lists given.
Implications of Research

This study explored how diabetes and periodontal disease are related and how the
treatment of one affects the other. The results of this research demonstrated that the
Periodontal Screening Tool is a possible solution in connecting CDCES and Oral Health
Care Professionals in support of each other in providing total patient care.
Research shows that periodontal therapy (controlling inflammation caused by
periodontal disease) increases the probability of controlling blood sugar levels, thus
reducing the long-term complications associated with diabetes. This supports the goal of
Healthy People 2030 to reduce the long-term complications associated with diabetes and
increase the use of oral healthcare systems.
Utilizing a Periodontal Screening Tool accompanied by an Education and
Training Module, as described in this study, could play an integral part in gaining
knowledge regarding the link between periodontal disease and other systemic diseases
and help connect patients with oral health professionals. Professional health care
organizations should consider promoting educational opportunities on topics such as the
oral-systemic link and inter-professional collaborative care.
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Many patients with systemic inflammatory diseases present with co-morbidities.
Providing a Periodontal Screening Tool for all health care professionals who treat
patients with systemic inflammatory diseases, such as diabetes, cardiovascular disease,
and rheumatoid arthritis could increase inter-professional collaboration and result in
overall healthier patient outcomes. Such a tool could have a major impact on the overall
health of the patient with co-morbidities. Introducing a screening tool for periodontal risk
factor assessment for non-dental professionals could translate to individuals with
systemic inflammatory diseases seeing their Dentist, Dental Therapist, or Dental
Hygienist for evaluation and treatment.
Limitations
The main limitation to this study was sample size. It has previously been

recommended that qualitative studies require a minimum sample size of at least 12 to
reach data saturation (Fugard & Potts, 2014). This is often a limitation for a Pilot Study.
A total of four CDCES completed this study. The small sample size might produce biased
results and the findings will be less conclusive. Recruiting CDCES from additional
hospitals and clinics could have increased participation. The non-parametric convenience
sample and lack of the control group limits the generalizability.
Another limitation of this pilot study was the two-week study period. CDCES
from Inland Northwest Health Services (INHS) were originally recruited for this study.
Between recruiting, enrollment, and implementation of this study, INHS was acquired by
Providence Medical. As a result, approval from Providence Medical Research Board was
required prior to implementation. This process took three weeks in committee, which
resulted in enrolling another group of CDCES to participate and shortened the duration of
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this study from four weeks to two weeks. Extending the duration of the study would have
provided more opportunities to use the Periodontal Screening Tool, which may have
strengthened the results.
The number of patients seen weekly and the number of completed Periodontal
Screening Tools were tracked; however, many patients were counseled strictly on
medications and insulin pump use. For this type of session, the use of the Periodontal
Screening Tool was inappropriate. It may have been helpful to track how any counseling
appointments were strictly medication use and insulin pump instruction.
Another limitation of this study is the design of the Periodontal Screening Tool.
For ease of use, it was a one-page document delivered as hard copy. The post-test
findings indicate some of the questions need clarification and fewer items were
suggested; thus, a shorter and more succinct tool may prove useful.
Recommendations/Suggestions for Future Research
The current study investigated the effect of a Periodontal Screening Tool,
accompanied by an Education and Training Module, on CDCES’s confidence in
informing the patient on periodontal disease risk factors and providing resources for the
patient to seek dental care. The results of this pilot study demonstrated that a full-scale
study is feasible. Suggestions to further this research are: 1) Utilize a larger sample size
by recruiting all medical providers who see or treat patients with diabetes, 2) Include all
settings where diabetes care and management take place and 3) Consider revising the
Periodontal Screening Tool to make it more concise and increase clarity.
One possibility for increasing the sample size and setting would be to include
hospitalists, who see every patient admitted to the hospital, many of whom will have
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diabetes. Upon initial intake, it would be determined whether the patient has been
diagnosed with diabetes, which would present the opportunity to use the Periodontal
Screening Tool. Revising the questions regarding the patient’s dental history could give
insight to the conversation regarding the oral-systemic link. Additionally, data could have
been addressed through focus groups of the CDCES providing a more qualitative piece.
Another suggestion for future research would be to test the Periodontal Screening
Tool as a way of perfecting it. Future research is needed to determine the most effective
way to educate CDCES about periodontal disease and diabetes and to determine the
impact of increased oral health education on their patients. An area of focus for the future
would be to develop an educational module regarding the bidirectional relationship
between inflammatory systemic diseases to further inter-professional education and
support collaborative care. Implementing this module in an inter-professional healthcare
setting as a professional development or continuing education course may prove
particularly beneficial, as discussion and collaboration may occur. Future studies are
needed to evaluate attitudes and perceptions regarding collaborative patient care,
specifically between healthcare professionals who treat patients with inflammatory
diseases. In addition, studies are needed to develop platforms from which to do this, such
as webinars, podcasts, and interactive digital offerings.
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Conclusions
Diabetes affects an estimated 422 million adults worldwide and this number is
expected to double or triple by 2050. Periodontal disease is the sixth most common
complication of diabetes. Because the long-term complication associated with diabetes
worsen over time, the need for collaborative care is evident. Periodontal therapy may
help reduce and control glycemic levels. Similarly, improved glycemic control may help
improve periodontal disease. Considering the potential impact of periodontitis on
glycemic control, thus increasing the risks of other diabetic complications, it is
paramount to include the treatment of periodontal disease as an integral element of
diabetes care. This research demonstrated the importance of providing a user-friendly
periodontal risk assessment tool for CDCES. Furthermore, this Periodontal Screening
Tool could be used by other healthcare professionals who treat patients with systemic
inflammatory diseases. Ultimately, this would increase inter-professional collaborative
care and could result in overall healthier patient outcomes, which supports the objectives
of Healthy People 2030 to reduce long-term complications associated with diabetes and
increase access to oral healthcare.
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Appendix A
Participant Cover Letter
Dear Diabetes Educators,
My name is Holly Brawner, and I am currently pursuing my Master of Science in
Dental Hygiene degree at Eastern Washington University. I would like to invite you to
participate in my thesis study titled A Pilot Study: Periodontal Risk Factor Evaluation
Tool for Certified Diabetes Care and Education Specialists. I currently practice dental
hygiene and live in Coeur d ‘Alene, Idaho. I am passionate about creating a bridge
between the medical and dental communities which has led me to focus my thesis on this
topic.
The purpose of this study is to test a periodontal disease risk assessment tool for
non-dental professionals. This study looks at a point of care Periodontal Screening Tool
to evaluate and promote periodontal care. This study will explore the periodontal diabetes
link and how to best promote this phenomenon, so patients are provided the medical and
dental care options when treating diabetes. It will explore inter-professional collaboration
between the medical and dental communities, specifically Certified Diabetes Care and
Education Specialists and Registered Dental Hygienists, as well as offer a possible
solution in connecting healthcare providers in support of each other in providing total
patient care. Providing a tool for periodontal disease risk assessment for CDCES and
patients could translate to individuals with poorly controlled HbA1c seeing the dentist or
dental hygienist for evaluation and treatment. Any risks associated with answering the
questions are minimal and do not exceed those encountered in daily life. You are not
likely to receive direct benefits from participating in this research study. However, your
responses may help me learn more about promoting periodontal care among individuals
with diabetes. In addition, the Principal Investigator (PI) hopes to identify possible
barriers to dental care.
As part of this research, you are asked to complete a Participant Demographic
Survey and Pre-test prior to participating in an Online Education and Training Module.
This survey includes informed consent and can be accessed via your email through the
SurveyMonkey link provided. This survey should take no more than 10 minutes to
complete. The online Education and Training Module will consist of a PowerPoint
presentation, lecture, and questions and answers. The 40-minute module will be presented
via Zoom at an agreed upon time and date prior to implementing the use of the
Periodontal Screening Tool and after pre-test submission. Participation in this study is
voluntary. You may skip any question you do not want to answer for any reason. As an
incentive, those who participate in the pre-test, post-test, and Education and Training
Module will be entered in a drawing for a Sonicare Toothbrush.
The duration of this study will be two weeks where you will be asked to use a
hard copy Periodontal Screening Tool to gather data for periodontal risk factors of each
patient being counseled. The one-page Periodontal Screening Tool includes a
demographic survey to gather data regarding the patient’s dental history, a list of risk
factors, and a decision tree for recommending dental care. A tear-off resource list is
included. When completed you will be asked to place them in an envelope for the PI to
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pick-up. All data collected from the pre and post-tests and Periodontal Screening Tools
will be kept confidential and only the PI (student) and a statistician will have access to
the information. The identity of all participants will remain confidential. At the
conclusion of this two-week study, you will be asked to complete an online post-test,
identical to the pre-test, with the addition of close-ended and open-ended questions,
which will be delivered via your email through the SurveyMonkey link provided. By
answering the survey questions, you are stating you are at least 18 years of age or older
and your consent to voluntarily participate in this research is implied.
______Yes, I agree

Signature____________________________

If you have any questions or concerns about this study, please contact Principal
Investigator Holly Brawner at (509) 979-6287 or hbrawner@eagles.ewu.edu or Thesis
Chair Ann O’Kelley Wetmore at awetmore@ewu.edu. If you have any concerns about
your rights as a participant in this research or any complaints you wish to make, you may
contact Charlene Alspach, Executive Director, Grant & Research Development, Eastern
Washington University at (509) 359-2517 or calspach@ewu.edu
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Appendix B
Demographic Survey and Pre-test
1. What is your age?
____25-34

____35-44

____45-54

____55-64

____65 and older

2. What is your gender?
_____male

_____female

____other

_____prefer not to answer

3. What degree do you hold?
_____Registered Nurse

_____Registered Dietitian

_____Pharmacist

____Other
If other, list profession___________________________________________
4. What is your practice setting?
_____specialty office _____hospital setting ____private practice ____other
If other, list practice setting_______________________________________
5. How long have you provided counseling and educational services to patients with
diabetes?
_____under 1 year

_____1-5 years

_____16-20 years

_____21-25 years

____6-10 years

____11-15 years

____26 years and longer

6. How many hours a week do you provide care to patients with diabetes?
___ 1-5

___6-10

___11-15

____16-20

____21-25

Pre-test
Please rank your confidence level
1. How confident are you counseling the patient about oral health?

____26 and over
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o Extremely confident
o Very confident
o Somewhat confident
o Not so confident
o Not at all confident
2. How confident are you in your knowledge about periodontal disease?
o Extremely confident
o Very confident
o Somewhat confident
o Not so confident
o Not at all confident
3. How confident are you in your knowledge of the bidirectional relationship between
diabetes and periodontal disease?
o Extremely confident
o Very confident
o Somewhat confident
o Not so confident
o Not at all confident
4. How confident are you in educating the patient about periodontal disease?
o Extremely confident
o Very confident
o Somewhat confident
o Not so confident
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o Not at all confident
5. How confident are you recommending the patient see the dentist or dental hygienist for
a periodontal evaluation?
o Extremely confident
o Very confident
o Somewhat confident
o Not so confident
o Not at all confident

Shared SurveyMonkey link
https://www.surveymonkey.com/r/X8V5SCW
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Appendix C
Education and Training Module
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Appendix D
Periodontal Screening Tool
CDCES Initials________
HbA1c 7.0 % or greater

___Yes

___No

Family history of periodontal disease
(gum disease, pyorrhea) mother, father,
sibling with tooth loss)

___Yes

___No

Cigarette Smoker

___Yes

___No

Brushes less than once per day

___Yes

___No

Flossing less than once per day

___Yes

___No

Taking anticonvulsants, immunosuppressants,
antihistamines, or narcotic analgesics

___ Yes

___No

Diagnosed cardiovascular disease
or rheumatoid arthritis
___Yes
___No
_______________________________________________________________________
If there are any yes answers, please ask the patient the following questions:
Patient Survey filled out by the CDE
Do you have a dental home?

___Yes

___No

If yes,
Were you referred to the dentist by a medical professional? ___Yes

___No

If not, will you accept a resource list?
Resource list given.
If you did not see the DDS, why not?
Fear

___Pain

___Cost

___No Dental Home

___Unawareness of Risk of Gum Disease

___Other

___Yes

___No

___Yes

___No
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If other, please specify____________________________________________________
______________________________________________________________________

Tear-0ff Resource List

EWU Dental Hygiene Clinic

(509) 828-1300

NIC Dental Hygiene Clinic

(208) 929-4014
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Appendix E
Post-test
Please rank your confidence level
1. How confident are you counseling the patient about oral health?
o Extremely confident
o Very confident
o Somewhat confident
o Not so confident
o Not at all confident
2. How confident are you in your knowledge about periodontal disease?
o Extremely confident
o Very confident
o Somewhat confident
o Not so confident
o Not at all confident
3. How confident are you in your knowledge of the bidirectional relationship between
diabetes and periodontal disease?
o Extremely confident
o Very confident
o Somewhat confident
o Not so confident
o Not at all confident
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4. How confident are you in educating the patient about periodontal disease?
o Extremely confident
o Very confident
o Somewhat confident
o Not so confident
o Not at all confident

5. How confident are you recommending the patient see the dentist or dental hygienist for
a periodontal evaluation?
o Extremely confident
o Very confident
o Somewhat confident
o Not so confident
o Not at all confident
6. Did using the Periodontal Screening Tool increase your confidence in recommending
patient for dental treatment? ____Yes

____No

7. Was training on the use of the Periodontal Screening Tool adequate?
____Yes

____No

8. Would you be likely to implement a periodontal risk factor evaluation tool such as the
Periodontal Screening Tool into your practice?

____Yes

9. What about the Periodontal Screening Tool was helpful?

____No
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________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
10. What addition(s) to the Periodontal Screening Tool would make it stronger?
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________

Shared SurveyMonkey link
https://www.surveymonkey.com/r/2PPF3F7
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Educational Module
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WORK EXPERIENCE
Eastern Washington University
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2019-Present
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2017-Present
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June 2016

87

PERIODONTAL RISK FACTOR EVALUATION TOOL
Graduate
Landmark Worldwide
Seminar Series:
Group Leader
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July 2015 -Present

